Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGR-3515 in advanced solid tumors
NCT06463340Phase 1Recruiting
- Sponsor
- Schrödinger
- Start
- Jun 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of SGR-3515 in solid tumor (advanced stage), sponsored by Schrödinger. Primary endpoints: Incidence and severity of adverse events, Incidence of Dose Limiting Toxicities and 2 more. Started Jun 2024; status: recruiting.
02
Drugs
SGR-3515
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06463340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06463340.